TY - JOUR T1 - <em>CYP1A1</em> I462V Genetic Polymorphism and Lung Cancer Risk in a Cohort of Men in Shanghai, China JF - Cancer Epidemiology Biomarkers &amp; Prevention JO - Cancer Epidemiol Biomarkers Prev SP - 987 LP - 991 VL - 9 IS - 9 AU - London, Stephanie J. AU - Yuan, Jian-Min AU - Coetzee, Gerhard A. AU - Gao, Yu-Tang AU - Ross, Ronald K. AU - Yu, Mimi C. Y1 - 2000/09/01 UR - http://cebp.aacrjournals.org/content/9/9/987.abstract N2 - Cytochrome P450 (CYP) CYP1A1 activates tobacco-related carcinogens. A point mutation at codon 462 in exon 7 of CYP1A1 results in a substitution of isoleucine by valine near the heme binding site. This mutation is rare in Caucasians but common in Japanese populations, in which association with increased risk of lung cancer has been reported. There are few data in other Asian populations. We investigated this I462V polymorphism using DNA from 214 incident cases of lung cancer and 669 controls in a prospective cohort study of 18,244 middle-aged and older men in Shanghai, China. The valine allele frequency was 0.138 among the control population. The I462V genotype was not appreciably associated with lung cancer risk overall. There was some suggestion that having at least one valine allele might be related to increased risk of lung cancer among smokers of &lt;20 cigarettes/day (odds ratio, 1.72; 95% confidence interval, 0.82–3.62), particularly among those with homozygous deletion of GSTM1 (odds ratio, 2.80; 95% confidence interval, 1.07–7.33), which is involved in the detoxification of activated tobacco carcinogens. In this Chinese cohort, with CYP1A1 valine allele frequency intermediate between Japanese and Caucasian populations, the I462V polymorphism is not related to lung cancer overall, but it might play a role at lower levels of cigarette smoking among subjects with impaired carcinogen detoxification as assessed by the GSTM1-null genotype. ER -